Skip to main content
Caplight Logo









Hangzhou Yuannang Biotechnology Co., Ltd.

Hangzhou Yuannang Biotechnology Co., Ltd.

Private
HangzhouHealthcare & Life Scienceshttps://www.premiumtimesng.com/

Last Round

Series A

Sep 11, 2025

Total Funding Raised

$14M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Hangzhou Yuannang Biotechnology Co., Ltd. is a biotechnology company that develops biodegradable bone adhesives for orthopedic trauma repair.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Advanced Materials, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

bone adhesivebiomaterialsorthopedic implantsbiodegradable materialsbone gluemedical devicefracture repairregenerative medicinebiomimetic adhesiveorthopedic surgeryNMPA approvalclinical trialssurgical hardwarebiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hangzhou Yuannang Biotechnology Co., Ltd. Comparables

Compare Hangzhou Yuannang Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.

Hangzhou Yuannang Biotechnology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
RevBio, Inc.
85%
Biomimetic Innovations
80%
Sanara Medtech Inc
70%

Hangzhou Yuannang Biotechnology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 11, 2025
Early FundingAug 1, 2022
AngelOct 1, 2021

Key People

Founding team and executive leadership

Musikilu Mojeed

Editor-in-Chief Chief Operating Officer

Executive Team

Hangzhou Yuannang Biotechnology Co., Ltd. Investors

Notable investors and investment history

Hangzhou Yuannang Biotechnology Co., Ltd. investors
InvestorRounds
Zheshang Venture CapitalAngel, Series A, Early Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 9, 2025

    Monthly visitors grew 56% MoM, reaching 2.3 million.

  • Sep 11, 2025

    $14M round led by Zheshang Venture Capital.

Hangzhou Yuannang Biotechnology Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Hangzhou Yuannang Biotechnology Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Hangzhou Yuannang Biotechnology Co., Ltd.'s valuation, stock price, and market status.

Is Hangzhou Yuannang Biotechnology Co., Ltd. a public or private company?

Hangzhou Yuannang Biotechnology Co., Ltd. is a private company.

What is the current stock price of Hangzhou Yuannang Biotechnology Co., Ltd.?

Hangzhou Yuannang Biotechnology Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.

How much is Hangzhou Yuannang Biotechnology Co., Ltd. worth (valuation)?

Valuation information for Hangzhou Yuannang Biotechnology Co., Ltd. is not publicly available.

Can I buy Hangzhou Yuannang Biotechnology Co., Ltd. stock?

Hangzhou Yuannang Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Hangzhou Yuannang Biotechnology Co., Ltd.'s last funding round?

Funding round information for Hangzhou Yuannang Biotechnology Co., Ltd. is not publicly available.

Who are the main investors in Hangzhou Yuannang Biotechnology Co., Ltd.?

Investor information for Hangzhou Yuannang Biotechnology Co., Ltd. is not publicly disclosed.

Will Hangzhou Yuannang Biotechnology Co., Ltd. IPO soon?

No public IPO plans have been announced for Hangzhou Yuannang Biotechnology Co., Ltd..

How can I track Hangzhou Yuannang Biotechnology Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hangzhou Yuannang Biotechnology Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHangzhou
Employee Range99
Year FoundedN/A
Last FundingSep 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?